Spire Wealth Management - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$2,197
-1.5%
1420.0%0.00%
Q2 2023$2,231
-22.6%
142
-18.9%
0.00%
Q1 2023$2,884
+144100.0%
175
+31.6%
0.00%
Q4 2022$2
-99.9%
1330.0%0.00%
Q3 2022$2,000
-60.0%
133
-63.7%
0.00%
Q2 2022$5,000
-28.6%
366
-22.9%
0.00%
Q1 2022$7,0000.0%475
-10.0%
0.00%
Q4 2021$7,000
-22.2%
528
-6.9%
0.00%
Q3 2021$9,000
-55.0%
567
-52.6%
0.00%
-100.0%
Q2 2021$20,000
-35.5%
1,196
-29.1%
0.00%0.0%
Q1 2021$31,0001,6880.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders